Skip to main content
THQ logo

Abrdn Healthcare Opportunities Fund (THQ) Fund Overview

Abrdn Healthcare Opportunities Fund (THQ) — price $17.67 (-2.27%), as of the Nov 19, 2026 trading session.

Educational signal · not a buy or sell recommendation · How to read this

$17.67 −$0.41 (-2.27%)

Abrdn Healthcare Opportunities Fund · THQ

Abrdn Healthcare Opportunities Fund (THQ) is a closed-end, balanced mutual fund managed by Tekla Capital Management LLC, investing in global public equity and debt securities within the healthcare sector.

Price as of Nov 19, 2026

Key Statistics

Not scored: this is a debt/preferred or other non-common instrument, or its reported market value does not match its share basis.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • BLK · BlackRock, Inc. · 59 /100
  • BX · Blackstone Inc. · 85 /100
  • BAM · Brookfield Asset Management · 79 /100

See all scored stocks →

Price & valuation

As of
MeasureValue
Latest provided price$17.67
Change on the day-2.27%
Shares traded on the day163.0K

Price & events

1 · What is it?

What is Abrdn Healthcare Opportunities Fund (THQ), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Abrdn Healthcare Opportunities Fund (THQ) is the company analyzed here. In Q2 FY2026 it reported revenue of $36M and net income of $25M.

2 · Latest results

What do the latest results show for Abrdn Healthcare Opportunities Fund (THQ)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of $36M.

Quarterly income statement — 3 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026$36M$25M$0.60 (diluted)
Q2 FY2025$20M-$61M-$1.47 (diluted)
Q4 FY2024$52M$66M$1.60 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Abrdn Healthcare Opportunities Fund (THQ)?

Short answer · as of

The distress and quality screens read Altman Z 1.75 · Piotroski F 3. Trailing ratios: ROE -4.0% · ROA -3.1% · current ratio 0.06 · earnings yield -3.6% · free-cash-flow yield -0.1%.

Data-derived red flags

  • Financial-distress signal — its Altman Z-Score of 1.75 sits in the distress zone (elevated bankruptcy risk).
  • Negative return on equity (-4.0%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held THQ in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported THQ in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

Abrdn Healthcare Opportunities Fund Stock: Key Questions Answered

These answers are editorial: 1 of these 1 answer is drawn from the THQ research dossier (written Jun 15, 2026 by gemini-2.5-flash). Figures in this section are not part of the source register.

How does Abrdn Healthcare Opportunities Fund make money in financial services?

Abrdn Healthcare Opportunities Fund (THQ) generates returns and revenue primarily through its investment activities within the financial services sector. As a closed-end fund, it aims to increase its net asset value (NAV) through capital appreciation of its equity investments in global healthcare companies, including those in pharmaceuticals, biotechnology, and healthcare services.

Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 9 figures on this page — 7 from Financial Modeling Prep (FMP) and 2 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.